Tae G Park

Title: Innovations in Controlled Drug Delivery by Tae G Park

Introduction

Tae G Park is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of drug delivery systems, particularly through his innovative work on polymer blends. His research focuses on enhancing the efficacy and control of drug release mechanisms.

Latest Patents

Tae G Park holds a patent for "Controlled drug delivery using polymer/pluronic blends." This invention involves the preparation of a new series of degradable polymeric matrices by blending polymers that degrade through hydrolysis, such as poly(L-lactic acid) (PLA), with nonionic Pluronic™ surfactants. The unique aspect of this patent is the ability to control the water content of the polymer blend films by mixing different types of block copolymers and adjusting their amounts. The blends exhibit a liquid-crystalline phase transition in aqueous solutions, indicating the formation of a gel-like structure within the polymer skeleton. Notably, the degradation rates of poly(lactic acid) remain unaffected by the blending process, while the hydration degree in these matrices is enhanced. When utilized as drug-releasing matrices, these blends effectively extend protein release and minimize the initial protein burst compared to pure polymers.

Career Highlights

Tae G Park is affiliated with the Massachusetts Institute of Technology, where he continues to advance research in drug delivery systems. His work has garnered attention for its potential applications in medical therapies and pharmaceutical formulations.

Collaborations

Tae G Park has collaborated with notable researchers, including Smadar Cohen and Robert Samuel Langer, who are also recognized for their contributions to the field of biomedical engineering.

Conclusion

Tae G Park's innovative work in controlled drug delivery systems exemplifies the intersection of polymer science and medicine. His contributions are paving the way for more effective therapeutic solutions.